Assessing clinical benefit in the treatment of pancreas cancer : gemcitabine compared to 5-fluorouracilBURRIS, H; STORNIOLO, A. M.European journal of cancer (1990). 1997, Vol 33, pp S18-S22, issn 0959-8049, SUP1Article

Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case―control studyHENRY, N. L; PCHEJETSKI, D; STEARNS, V et al.British journal of cancer. 2010, Vol 103, Num 3, pp 291-296, issn 0007-0920, 6 p.Article

Spontaneous hemoperitoneum in two patients with myeloproliferative disordersSTORNIOLO, A. M; FITZGERALD, D. B; ROWE, J. M et al.American journal of hematology. 1987, Vol 24, Num 4, pp 433-435, issn 0361-8609Article

A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancerBURSTEIN, H. J; STORNIOLO, A. M; FRANCO, S et al.Annals of oncology. 2008, Vol 19, Num 6, pp 1068-1074, issn 0923-7534, 7 p.Article

Recombinant human erythropoeitin therapy for anemic cancer patients on combination chemotherapyCASE, D. C; BUKOWSKI, R. M; SALMON, S. E et al.Journal of the National Cancer Institute. 1993, Vol 85, Num 10, pp 801-806, issn 0027-8874Article

Improvements in survival and Clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : A randomized trialBURRIS, H. A; MOORE, M. J; NELSON, R et al.Journal of clinical oncology. 1997, Vol 15, Num 6, pp 2403-2413, issn 0732-183XArticle

Decadose effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract. II: Clinical studiesROBBINS, K. T; STORNIOLO, A. M; HRYNIUK, W. M et al.The Laryngoscope. 1996, Vol 106, Num 1, pp 37-42, issn 0023-852X, 1Article

Chronic myelomonocytic leukemiaSTORNIOLO, A. M; MOLONEY, W. C; ROSENTHAL, D. S et al.Leukemia. 1990, Vol 4, Num 11, pp 766-770, issn 0887-6924, 5 p.Article

Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and AgeDESTA, Z; KREUTZ, Y; HOFFMANN, E et al.Clinical pharmacology and therapeutics. 2011, Vol 90, Num 5, pp 693-700, issn 0009-9236, 8 p.Article

Sponge-gel-supported histoculture drug-response assay for head and neck cancer : correlations with clinical response to cisplatinROBBINS, K. T; CONNORS, K. M; STORNIOLO, A. M et al.Archives of otolaryngology, head & neck surgery. 1994, Vol 120, Num 3, pp 288-292, issn 0886-4470Article

High-dose carboplatin chemotherapy with GM-CSF and peripheral progenitor cell support : a model for delivering repeated cycles of dose-intensive therapySHEA, T. C; MASON, J. R; STORNIOLO, A. M et al.Cancer treatment reviews. 1993, Vol 19, pp 11-20, issn 0305-7372, SUPCConference Paper

Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapyHENRY, N. L; NGUYEN, A; FLOCKHART, D. A et al.British journal of cancer. 2010, Vol 102, Num 2, pp 294-300, issn 0007-0920, 7 p.Article

An Investigational new drug treatment program for patients with gemcitabine : Results for over 3000 patients with pancreatic carcinomaSTORNIOLO, A. M; ENAS, N. H; BROWN, C. A et al.Cancer. 1999, Vol 85, Num 6, pp 1261-1268, issn 0008-543XArticle

Rapid superselective high-dose cisplatin infusion for advanced head and neck malignanciesROBBINS, K. T; STORNIOLO, A. M; KERBER, C et al.Head & neck. 1992, Vol 14, Num 5, pp 364-371, issn 1043-3074Conference Paper

Drug response of head and neck tumors in native-state histocultureROBBINS, K. T; VARKI, N. M; STORNIOLO, A. M et al.Archives of otolaryngology, head & neck surgery. 1991, Vol 117, Num 1, pp 83-86, issn 0886-4470, 4 p.Article

Aromatase inhibitor-induced modulation of breast density: clinical and genetic effectsHENRY, N. L; CHAN, H.-P; OESTERREICH, S et al.British journal of cancer. 2013, Vol 109, Num 9, pp 2331-2339, issn 0007-0920, 9 p.Article

A review of hemolytic uremic syndrome in patients treated with gemcitabine therapyFUNG, M. C; STORNIOLO, A. M; NGUYEN, B et al.Cancer. 1999, Vol 85, Num 9, pp 2023-2032, issn 0008-543XArticle

Preclinical, pharmacologic, and phase I studies of gemcitabineSTORNIOLO, A. M; ALLERHEILIGEN, S. R. B; PEARCE, H. L et al.Seminars in oncology. 1997, Vol 24, Num 2, pp S7-2, issn 0093-7754, -S7-7, SUP7Article

Sequential cyles of high-dose carboplastin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells : a novel and effective method for delivering multiple courses of dose-intensive therapySHEA, T. C; MASON, J. R; STORNIOLO, A. M et al.Journal of clinical oncology. 1992, Vol 10, Num 3, pp 464-473, issn 0732-183XArticle

A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicinSCHWARTZ, G. K; WARD, D; KELSEN, D. P et al.Clinical cancer research. 1997, Vol 3, Num 4, pp 537-543, issn 1078-0432Article

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerROTHENBERG, M. L; MOORE, M. J; STORNIOLO, A.-M et al.Annals of oncology. 1996, Vol 7, Num 4, pp 347-354, issn 0923-7534, 7 p.Article